Validity of Self-Reported Drug Use Information Among Pregnant Women
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
IntroductionThis study assesses validity of self-report for the use of major classes of illicit drugs and opioid-maintenance therapy among pregnant women at a substance abuse treatment program.MethodsAnalyses used data collected from 83 pregnant women in a prospective cohort study at the University of New Mexico. Study participants with a history of substance abuse were screened and, if eligible, enrolled during an early prenatal care visit. A follow-up interview was conducted shortly after delivery. Self-reported information about drug use later in pregnancy was compared with urine drug screen (UDS) results collected during the third trimester. Simple kappa (k) and prevalence-and-bias-adjusted kappa (PABAK) coefficients were calculated as the measures of agreement. Sensitivity and specificity of self-report for each drug class were estimated using UDS as the ‘gold standard’.ResultsThe sample included a large proportion of ethnic minority (80 % Hispanic/Latina and 7 % American Indian) and socially disadvantaged (50 % less than high school education and 94 % Medicaid-insured) pregnant women. On average, patients had 4.8 ± 3.0 urine drug screens during the third trimester. Sensitivity of self-report was low (<60 %) for all classes of illicit drugs; however, marijuana and opioids demonstrated slightly higher sensitivity (57.9 and 58.3 %, respectively) than other classes (<47 %).ConclusionsThis study found substantial underreporting for all classes of illicit drugs among pregnant women in a substance abuse treatment program. Rates of underreporting are expected to be higher among the general population of pregnant women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · PubMed · Cited by 7,011
The kappa statistic in reliability studies: use, interpretation, and sample size requirements
Sim, J., & Wright, C. C. (2005) · Physical Therapy · doi:10.1093/ptj/85.3.257 · Cited by 4,093 · cited 1×
“In order to overcome the dependence of kappa statistic on prevalence, a limitation known as kappa paradox [30], prevalence-and-bias adjusted kappa (PABAK) was also calculated.”
MethodSensitive questions in surveys.
Tourangeau, R., & Yan, T. (2007) · Psychological Bulletin · doi:10.1037/0033-2909.133.5.859 · Cited by 3,057 · cited 1×
“It is thus relied upon for national public health surveys [32], and has gained increasing popularity as a key component in screening and motivational interviewing [21].”
Background(2013) · Clinical Handbook of Chinese Medicine · doi:10.1142/9789814366137_0005 · Cited by 1,165
Validity of self-evaluation of ability: A review and meta-analysis.
Mabe, P. A., & West, S. G. (1982) · Journal of Applied Psychology · doi:10.1037//0021-9010.67.3.280 · Cited by 973
(2014) · Encyclopedia of Social Deviance · doi:10.4135/9781483340470.n189 · Cited by 630
Lundahl, B., & Burke, B. L. (2009) · Journal of Clinical Psychology · doi:10.1002/jclp.20638 · Cited by 573 · cited 1×
“It is thus relied upon for national public health surveys [32], and has gained increasing popularity as a key component in screening and motivational interviewing [21].”
BackgroundTalk is cheap: measuring drinking outcomes in clinical trials.
Babor, T. F., Steinberg, K., Anton, R., & Del Boca, F. (2000) · Journal of Studies on Alcohol · doi:10.15288/jsa.2000.61.55 · Cited by 468 · cited 1×
“Numerous additional factors that can affect social desirability biases have been recognized, including patient characteristics (such as pregnancy), interview setting, and patients’ fears of possible disciplinary actions [1, 9].”
BackgroundTruth or consequences: the validity of self‐report data in health services research on addictions
Del Boca, F. K., & Noll, J. A. (2000) · Addiction · doi:10.1046/j.1360-0443.95.11s3.5.x · Cited by 467
Buprenorphine and Buprenorphine/Naloxone Diversion, Misuse, and Illicit Use: An International Review
A. Yokell, M., D. Zaller, N., C. Green, T., & D. Rich, J. (2011) · Current Drug Abuse Reviewse · doi:10.2174/1874473711104010028 · Cited by 398
Increase in Prescription Opioid Use During Pregnancy Among Medicaid-Enrolled Women
Desai, R. J., Hernandez-Diaz, S., Bateman, B. T., & Huybrechts, K. F. (2014) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000208 · Cited by 346
Harrison, L., & US Department of Health and Human Services; National Institute on Drug Abuse (1997) · PsycEXTRA Dataset · doi:10.1037/e495622006-003 · Cited by 260 · cited 1×
“Prior studies have described how different drugs are often perceived with varying degrees of stigma, and how the perceived stigmatization of a particular drug may change depending on the context [14, 15].”
BackgroundTruth or consequences: the validity of self-report data in health services research on addictions
Boca, F. K. D., & Noll, J. A. (2000) · Addiction · doi:10.1080/09652140020004278 · Cited by 251
Initial Validation of a Self-Report Measure of the Extent of and Reasons for Medication Nonadherence
Voils, C. I., Maciejewski, M. L., Hoyle, R. H., Reeve, B. B., Gallagher, P., Bryson, C. L., & Yancy, W. S. (2012) · Medical Care · doi:10.1097/mlr.0b013e318269e121 · Cited by 173 · cited 1×
“However, the validity of self-report as a screening method for stigmatized health behaviors is complex [13, 17, 34].”
BackgroundLange, S., Shield, K. D., Koren, G., Rehm, J. T., & Popova, S. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-127 · Cited by 161 · cited 1×
“Although analysis of drug metabolites provides a more objective measure of recent drug use [4, 18, 20, 24], biomarker testing poses several limitations in the clinical setting.”
BackgroundOverview and Epidemiology of Substance Abuse in Pregnancy
WENDELL, A. D. (2013) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e31827feeb9 · Cited by 143 · cited 1×
“These prevalence data are generally considered to be a conservative estimate due to the effects of underreporting [36].”
BackgroundBar‐Oz, B., Klein, J., Karaskov, T., & Koren, G. (2003) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.88.2.f98 · Cited by 123
Just Say “I Don't”: Lack of Concordance Between Teen Report and Biological Measures of Drug Use
Delaney-Black, V., Chiodo, L. M., Hannigan, J. H., Greenwald, M. K., Janisse, J., Patterson, G., Huestis, M. A., Ager, J., & Sokol, R. J. (2010) · Pediatrics · doi:10.1542/peds.2009-3059 · Cited by 106 · cited 1×
“This is consistent with previous studies, which concluded that frequent users tend to underreport both the amount and frequency of their substance use in comparison to occasional users [10, 38].”
ResultPunishing pregnant drug users: enhancing the flight from care
Poland, M. L., Dombrowski, M. P., Ager, J. W., & Sokol, R. J. (1993) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(93)90001-7 · Cited by 106 · cited 1×
“It is important to consider the effects of such laws on women’s willingness to accurately report their substance use, especially as a measure of help-seeking [25, 35].”
BackgroundResults of hair analyses for drugs of abuse and comparison with self-reports and urine tests
Mußhoff, F., Driever, F., Lachenmeier, K., Lachenmeier, D. W., Banger, M., & Madea, B. (2005) · Forensic Science International · doi:10.1016/j.forsciint.2004.07.024 · Cited by 105 · cited 1×
“Although analysis of drug metabolites provides a more objective measure of recent drug use [4, 18, 20, 24], biomarker testing poses several limitations in the clinical setting.”
BackgroundSelf-report of illicit substance use versus urine toxicology results from at-risk pregnant women
Yonkers, K. A., Howell, H. B., Gotman, N., & Rounsaville, B. J. (2010) · Journal of Substance Use · doi:10.3109/14659891003721133 · Cited by 95 · cited 2×
“and other developed countries has been increasingly documented [37, 38].”
BackgroundResultRational use and interpretation of urine drug testing in chronic opioid therapy.
Reisfield, G. M., Salazar, E., & Bertholf, R. L. (2007) · PubMed · Cited by 92
WINSTOCK, A. R., Lea, T., & Sheridan, J. L. (2008) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2007.03.002 · Cited by 92 · cited 1×
“and other developed countries has been increasingly documented [37, 38].”
BackgroundNational Survey on Drug Use and Health, 2011: Archival Version
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2012) · ICPSR Data Holdings · doi:10.3886/icpsr34481 · Cited by 87
El Marroun, H., Tiemeier, H., Jaddoe, V. W. V., Hofman, A., Verhulst, F. C., van den Brink, W., & Huizink, A. C. (2011) · European Addiction Research · doi:10.1159/000320550 · Cited by 86 · cited 1×
“Prior studies have typically focused on only one or two drug classes [5, 12], or com-”
Chermack, S. T., Roll, J. M., Reilly, M. P., Davis, L., Kilaru, U., & Grabowski, J. G. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00106-4 · Cited by 83
Bakhireva, L. N., Leeman, L. M., Savich, R. D., Cano, S., Gutierrez, H. L., Savage, D. D., & Rayburn, W. F. (2014) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12349 · Cited by 78 · cited 2×
“The study methodology has been described elsewhere [2, 3].”
BackgroundMethodSelf-citationHarrell, A. V., & US Department of Health and Human Services; National Institute on Drug Abuse (1997) · PsycEXTRA Dataset · doi:10.1037/e495622006-004 · Cited by 78 · cited 1×
“Prior studies have described how different drugs are often perceived with varying degrees of stigma, and how the perceived stigmatization of a particular drug may change depending on the context [14, 15].”
BackgroundGreenfield, T. K., Nayak, M. B., Bond, J. C., Kerr, W. C., & Ye, Y. (2014) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12480 · Cited by 35 · cited 1×
“However, the validity of self-report as a screening method for stigmatized health behaviors is complex [13, 17, 34].”
BackgroundLambert, B., Scheiner, M., & Campbell, D. E. (2010) · Journal of Addictive Diseases · doi:10.1080/10550881003684673 · Cited by 18 · cited 1×
“Foremost are the complex ethical issues associated with screening in vulnerable populations, such as pregnant women [19].”
BackgroundJain, R., Balhara, Y. P. S., Jhanjee, S., & Sethi, H. (2012) · Substance Abuse · doi:10.1080/08897077.2011.630947 · Cited by 12 · cited 1×
“However, the validity of self-report as a screening method for stigmatized health behaviors is complex [13, 17, 34].”
BackgroundJain, R., Quraishi, R., Majumder, P., & Pattanayak, R. (2013) · Journal of Substance Use · doi:10.3109/14659891.2012.674625 · Cited by 8 · cited 1×
“Although analysis of drug metabolites provides a more objective measure of recent drug use [4, 18, 20, 24], biomarker testing poses several limitations in the clinical setting.”
Background
Cited by
Associations Between Prenatal Cannabis Exposure and Childhood Outcomes: Results From the ABCD Study
Paul, S. E., Hatoum, A. S., Fine, J. D., Johnson, E. C., Hansen, I., Karcher, N. R., Moreau, A. L., Bondy, E., Qu, Y., Carter, E. B., et al. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.2902 · Cited by 329
Cannabis use during pregnancy: Pharmacokinetics and effects on child development
Grant, K. S., Petroff, R., Isoherranen, N., Stella, N., & Burbacher, T. M. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.08.014 · Cited by 255
Mark, K., Gryczynski, J., Axenfeld, E., Schwartz, R. P., & Terplan, M. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000299 · Cited by 172
“The data collected are all self-reported, which is subject to recall bias and underreporting due to fear of loss of confidentiality and social desirability (Garg et al., 2016).”
Background
Metadata
- Authors
- Garg, M., Garrison, L., Leeman, L., Hamidovic, A., Borrego, M., Rayburn, W. F., & Bakhireva, L.
- Venue
- Maternal and Child Health Journal
- Published
- 2015-07-15
- Volume
- 20
- Issue
- 1
- Pages
- 41-47
- ISSN
- 1092-7875 (ISSN-L)
- 1573-6628
- OpenAlex
- W2113372923
- Cited by
- 161
- References
- 32
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.